Skip to content
Home/Companies/Biotech/Dualyx

Dualyx

Biotech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Dualyx?

Dualyx is a French Biotech company, currently owned by Andera Partners since 2023.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 6 · 2022 · VC

Key facts

HQFrance
SectorBiotech

More from BioDiscovery 6

Other portfolio companies in the same fund.

Inventiva
Inventiva
Active
BiotechFrance· 2024
Kestra Medical Technologies
Kestra Medical Technologies
Exited 2025
MedTechUS· 2024
SciRhom
Active
BiotechFrance· 2024
Abivax
Abivax
Active
BiotechFrance· 2023
Ariceum
Active
BiotechFrance· 2023
BioVentrix
BioVentrix
Active
MedTechFrance· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Dualyx?

Dualyx is currently owned by Andera Partners, through BioDiscovery 6, since 2023.

When did Andera Partners acquire Dualyx?

Andera Partners acquired Dualyx in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue